Key facts
- It has raised $25.5M across 2 recorded rounds; the latest was Early Stage VC ($12.7M) in Nov 2024.
- Notable investors include Y Combinator, Gaingels, Metaplanet Holdings, Initialized Capital, Day One Ventures — 36 tracked in total.
- Mindstate Design Labs has filed 1 Form D with the SEC, most recently Nov 2024 ($12.7M sold to 43 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 36 names
- ·Watchlist + deal alerts for Mindstate Design Labs
Funding rounds
2 roundsAbout Mindstate Design Labs
Developer of psychedelic-inspired therapeutics designed for intractable mental and behavioral health conditions. The company's Artificial Intelligence neuroengineering platform uses natural history and computational methods to predict the acute effects of serotonergic agonists in humans, enabling healthcare institutions to alter states of consciousness for mental health therapeutics and develop novel classes of psychoactive small-molecule therapeutics for psychiatric indications.
- Industry
- Drug Discovery
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2021
- Employees
- 7
- Website
- mindstate.design/
- Ownership
- Privately Held (backing)
Mindstate Design Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mindstate Design Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mindstate Design Labs in its N-PORT filings yet. We sweep new filings monthly.